BioCity Nottingham
BioCity Nottingham is a bioscience science park in central Nottingham in the United Kingdom. It is the UK's largest bioscience innovation and incubation centre. History. In 2002, laboratories and office space were donated to Nottingham Trent University by BASF. Biocity was founded in September 2003 by the University of Nottingham, Nottingham Trent University (NTU) and the East Midlands Development Agency (which was based close to BioCity). Biocity's premises were developed from the building donated by BASF. Phase 1 was completed in March 2004, providing of space, then Phase 2 in March 2006 provided . When Phase 3  of the development was completed in October 2008, with , funding from emda also finished. Background. Nottingham has a history of bioscience research done at the University of Nottingham, Nottingham Trent University and by Boots, Britain's largest retail pharmacy company, which is based in Dunkirk/Beeston. Although Boots no longer engages in drug discovery, Ibuprofen (iso-butyl-propanoic-phenolic acid) was created by a team of Boots scientists including Stewart Adams and John Nicholson. In November 2013 work on ibuprofen was recognised by the erection of a Royal Society of Chemistry blue plaque on the site of the original laboratory  where the painkiller was developed. The plaque reads: In March 2005 Nottingham was named as a Science City; the other 5 Science Cities were Birmingham, Bristol, York, Newcastle and Manchester. Structure. It is situated in former BASF buildings, which previously were used by Boots as research laboratories. The site on Pennyfoot Street, between the A60 and A612, is for bioscience SMEs. The University of Nottingham has the largest collaboration with companies at BioCity, with a few having links with NTU. There are three buildings – In January 2012 BioCity opened a second site, BioCity Scotland, resulting from the acquisition of a  former MSD research facility near Glasgow.